Adults taking the novel once-daily oral pill for plaque psoriasis had significantly higher rates of clear or almost clear ...

The table is a review of notable updates that occurred in February 2025 for investigational products in development.

Multiple risk factors were associated with denials and longer wait times for biologic treatment in moderate to severe asthma, ...

Twice-daily application of ruxolitinib cream demonstrated an ability to reduce itching and blistering in prurigo nodularis, a ...

Twice-daily deucravacitinib 3 mg and 6 mg significantly improved cutaneous lupus erythematosus activity by week 16, according ...

Science fair director Rose Heritage-Pérez has spent decades showing students that they can make a career in the STEM fields.

Request To Download Free Sample of This Strategic Report @- https://reportocean.com/industry-verticals/sample-request?report_id=bw8527 ...

Greykasell Wealth Strategies Inc. acquired 708 shares of Regeneron Pharmaceuticals, valued at approximately $504,000. Other ...

The appeals court for the Federal Circuit upheld a lower court’s ruling, finding that Regeneron has not sufficiently ...

Dupilumab added to standard COPD triple therapy reduces the annual rate of moderate exacerbations but not severe exacerbations.

Two Native high school students are among the recent winners of one of the most prestigious science research competitions.